News Global regulators seek permanent working group on AI Rapid advances in the use of artificial intelligence (AI) in healthcare and medicines development are at risk of outstrip
Views & Analysis ICMRA seeks international alignment on COVID-19 product asse... COVID-19 drugs, vaccines and diagnostics that are developed and tested within new international guidelines can expect rapid assessment and authorisation.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
